Sort
261,768 grants matching “gene therapy”
Mechanistic and translational studies of CBF leukemia
$989,695Paul Liu · National Human Genome Research Institute · ZIA · FY2014 · HG
Malaria Transmission Blocking Vaccine Discovery
$989,562Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Deciphering mechanisms of Listeria placental-fetal invasion
$989,468Nancy Freitag · University Of Illinois At Chicago · R01 · FY2025 · AI
Development of synthetic sphingolipids for prostate cancer therapy
$989,405Alison Nicole McCracken · Siege Pharmaceuticals, Inc. · R44 · FY2021 · CA
AsthmaNet: Brigham and Women's Hospital & Children's Hospital Boston
$989,393Elliot Israel · Brigham And Women'S Hospital · U10 · FY2012 · HL
Hemorrhagic and Ischemic Stroke Among Blacks and Whites
$989,353University Of Cincinnati · R01 · FY2004 · NS
A polymeric biomaterial-based vaccine utilizing immunomodulatory agents and antigen for the amelioration of type 1 diabetes.
$989,307Benjamin Michael Looney · Onevax, Llc · R44 · FY2020 · DK
Cytokines in AIDS and Cancer Immunotherapy
$989,274George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency
$989,251Alan S. Wayne · Children'S Hospital Of Los Angeles · U01 · FY2023 · AI
Improved bacterial strains for therapeutic DNA and protein production
$989,190Frederick R Blattner · Scarab Genomics, Llc · R44 · FY2009 · GM
Preclinical development of novel small molecule malaria drugs that overcome drug
$989,081David H Peyton · Designmedix, Inc. · R42 · FY2014 · AI
Menopausal transition - a window of susceptibility for the promotion of breast cancer by environmental exposures
$989,046Shiuan Chen · Beckman Research Institute/City Of Hope · U01 · FY2016 · ES
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
$988,986Suresh Ambudkar · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Multi-Omic Single-Cell System for Improved Combination Cancer Immunotherapy Monitoring and Implementation
$988,980Timothy S McConnell · Isoplexis, Inc. · R44 · FY2020 · CA
Novel immunotherapy against MOG antibody disease
$988,943Weston Daniel · Evoq Therapeutics, Inc. · R44 · FY2025 · TR
Biomarkers of Chronic Kidney Disease
$988,923Joseph Vincent Bonventre · Brigham And Women'S Hospital · U01 · FY2019 · DK
Development of a TRAIL-based therapy for alcohol related chronic pancreatitis
$988,751Victor V Roschke · Theraly Fibrosis, Inc. · U44 · FY2018 · AA
From Structure to Therapy: The TRiC Chaperonin Network in Huntington's Disease
$988,674Leslie Michels Thompson · University Of California-Irvine · P01 · FY2020 · NS
Studies Of Hereditary Neurological Disease: Disease Gene Identification
$988,642Kenneth Fischbeck · National Institute Of Neurological Disorders And Stroke · ZIA · FY2009 · NS
A new approach to monitoring glycosylation during glycoprotein production
$988,601Loretta Yang · Lectenz Bio, Inc. · R44 · FY2023 · GM
Multiplexed, Non-Amplified, Nucleic Acid-Based Identification of Multidrug Resistant Pathogens Using an Integrated Optofluidic Platform
$988,510Aaron R. Hawkins · Brigham Young University · R01 · FY2018 · AI
A Phase 1b Multiple Ascending Dose Study of the Safety and Tolerability of BMS-984923 in Alzheimer's Disease
$988,498Adam Peter Mecca · Yale University · R01 · FY2023 · AG
Development of Synthetic High-Density Lipoproteins for Treatment of Sepsis
$988,469Elke Lipka · Tsrl, Inc. · R44 · FY2022 · GM
Chimeric Alphavirus Vaccines for Chikungunya
$988,452Scott C Weaver · University Of Texas Med Br Galveston · U01 · FY2009 · AI
InflammaGut: a drug-screenable co-culture system using gut-associated lymphocytes and autologous primary human gut epithelium that reports inflammation
$988,414Bill Thelin · Altis Biosystems, Inc. · R44 · FY2023 · TR